secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001628280-25-007553
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth reports FY2024 net income of $90.4M vs prior year loss; revenue up 1.9%
--------------------------------------------------------------------------------

- FY2024 net revenue $3.261B (+1.9% YoY); net income attributable $90.4M vs net loss $678.9M.
- Adjusted EBITDA $688.7M (+2.7% YoY); cash flow from ops $541.8M, free cash flow $235.8M.
- Q4 net revenue $856.6M (-0.2% YoY); net income $50.3M vs loss $254.5M; adjusted EBITDA $200.6M.
- FY2025 guidance: net revenue $3.22B-$3.36B; adjusted EBITDA $670M-$710M; free cash flow $180M-$220M.
- Reached definitive agreement to sell certain incontinence assets in Wellness at Home segment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828025007553/0001628280-25-007553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828025007553/ahco-20250225.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-007553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer